No Data
BD to Announce Financial Results for Its Third Quarter of Fiscal 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results...
Becton Dickinson Is Maintained at Outperform by Evercore ISI Group
Becton Dickinson Is Maintained at Outperform by Evercore ISI Group
Becton Dickinson Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 24.62% Evercore ISI Group $290 → $285 Maintains Outperform 05/30/2024 19.81% Goldman Sachs → $2
Evercore Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $285
Evercore analyst Vijay Kumar maintains $Becton Dickinson & Co(BDX.US)$ with a buy rating, and adjusts the target price from $290 to $285.According to TipRanks data, the analyst has a success rate of 4
Evercore ISI Adjusts Price Target on Becton, Dickinson to $285 From $290, Maintains Outperform Rating
Becton, Dickinson (BDX) has an average outperform rating and a price target range of $240 to $325, according to analysts polled by Capital IQ. Price: 229.86, Change: +0.59, Percent Change: +0.26
BD's (BDX) New Research Tool to Aid Single-Cell Analysis